PM Defends Chancellor Amid Forecast Controversy; UK Secures Critical Pharma Trade Deal with US

The Prime Minister has come to the staunch defense of Chancellor Reeves, asserting that she did not mislead the public despite growing pressure over her recent economic statements. This development coincides with a significant new agreement between the United Kingdom and the United States concerning pharmaceutical tariffs.

Over the past weekend, Chancellor Reeves faced intensified scrutiny following accusations that she withheld positive aspects of economic forecasts during a speech delivered on November 4. Critics alleged that the Chancellor failed to provide a complete picture to both the public and the cabinet, claims she has vehemently denied. Millenium TV has learned the Prime Minister’s intervention aims to quash these concerns, with a clear statement of support for the Chancellor’s actions.

Separately, the UK and US have successfully concluded a deal that will maintain zero tariffs on pharmaceutical shipments originating from the United Kingdom to America for the next three years. Under the terms of this pivotal agreement, the UK’s National Health Service (NHS) is expected to increase its expenditure on medicines. This reciprocal arrangement is designed to safeguard the unimpeded flow of British pharmaceutical exports into the American market while ensuring stable medicine supplies within the UK.